venture capital investors
venture capital investors

As an ATV venture partner, Ken focuses on the life sciences, including pharmaceuticals, bio-pharmaceuticals, in-vitro diagnostics and research products.

Ken is currently a senior partner at L.E.K. Consulting LLP and head of its European Life Sciences Practice.

Previously, he was senior vice president of Corporate Development for Applera Corporation; Vice President for the global consultancy Booz Allen & Hamilton, where he was head of its European Biopharmaceuticals Practice. Ken currently serves on the Board of Directors of Orchid Biosciences Inc. and Intercept Biopharmaceuticals Inc.

During his academic career, Ken authored over 50 articles on cell biology/cell replication.

Representative Investment

Helixis